Thermo Fisher Scientific (TMO) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Thermo Fisher Scientific (TMO) do?
Thermo Fisher Scientific Inc (TMO) is a U.S.-listed company in Healthcare (Diagnostics & Research). What it does: Develops specialized lab equipment, diagnostic kits, and drug discovery tools. Produces commercial biologic therapies under contract for external pharmaceutical companies. Supplies the entire scientific workflow from basic laboratory consumables to contracted commercial pharmaceutical. It is worth $255.19B on the market and sold $47.35B over the last year.
- Market cap
- $255.19B
- P/E ratio
- 36.3×
- Annual sales
- $47.35B
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Brief updated
- Nov 15, 2026
Brands and businesses behind TMO
- Fisher Scientific: Distributes third-party and proprietary supplies, chemicals, and equipment directly to enterprise research labs.
- Applied Biosystems: Sells instruments and testing kits used for genetic sequencing, forensic identification, and PCR analysis.
- Invitrogen: Produces antibodies, cell biology reagents, and cloning kits sold to scientific research institutions.
- Patheon: Provides contract development and sterile manufacturing services for commercial pharmaceuticals.
- PPD: Conducts outsourced clinical trials, laboratory testing, and regulatory filings for pharmaceutical drug developers.
- Gibco: Manufactures cell culture media, sera, and reagents critical for protein and vaccine production.
TMO’s flags, in plain English
Each flag is a number from Thermo Fisher Scientific’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 15, 2026.
Stupid Cash
Can pay this year's bills 1.8 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.
Fat Margins
Profit margin of 14.9%. The company keeps a healthy share of each sale as profit, which gives it room when costs jump.
Wide Gross Margin
Gross margin of 40.5% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.
Priced for Perfection
Priced at 36.3 times its yearly profit, so a lot of growth is already expected. The share price already assumes strong results, so news that is merely good can still send it down.
Questions about TMO
How big is Thermo Fisher Scientific?
Thermo Fisher Scientific’s market cap is $255.19B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $47.35B: what customers paid the company over the last year, before any costs.
What is TMO’s P/E ratio?
TMO’s P/E ratio is 36.3×. Investors pay about 36.3 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.
What could go wrong with TMO?
Biopharma customers have significantly reduced equipment orders following post-pandemic budget cutbacks. That is one risk on Thermo Fisher Scientific’s card. Its first risk flag is Priced for Perfection, explained above. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Thermo Fisher Scientific’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. TMO’s filings on SEC.gov. The Margin Monkey is research, not advice.
